Pediatrics

Officials with the FDA approved fenfluramine (Fintepla, Zogenix) oral solution, CIV for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.

The FDA warned that the dosing cups, which were missing some graduation markings, could cause an accidental overdose.

The phase 2/3 trials will evaluate remdesivir (Gilead) in pediatric patients, from newborns to adolescents, who have contracted severe COVID-19 symptoms.

EndeavorRx (Akili Interactive), a prescription-only game-based device, is indicated for use in children ages 8 to 12 years old with primarily inattentive or combined-type ADHD who have demonstrated an attention issue.

The study warned that, with 74 million children in the United States, PICU resources could face concerning strain from COVID-19.

The study estimates that for each child in the PICU for COVID-19, another 2381 children are infected with the virus.

Pediatricians stress the importance of understanding the effects of COVID-19 on children.

The FDA previously approved sofosbuvir and velpatasvir to treat HCV in adults.

More than one-third of all children in the United States are not following the recommended vaccine schedule, according to a new study.

Strategies include nonpharmacologic therapies, nonopioid medications, and opioid rotation. 

Managing post-summer medication changes. 

Prepare for the back-to-school rush!

Natal conditions may influence susceptibility.

Lack of trust in vaccines abetted by online articles and past wrongdoing by the drug industry.

First non-insulin drug for pediatric use approved in nearly 20 years.

Zolgensma (onasemnogene abeparvovec-xioi) is an adeno-associated virus vector-based gene therapy

North Carolina working to expand the number of vaccines pharmacists can administer.

HZ in children is uncommon and is 10 times less common in kids who’ve been vaccinated against chickenpox.

Anthelmintic tablet for patients 6 years of age and older.

Each year, approximately 200,000 children ages 17 years and younger land in emergency departments (EDs) from adverse drug events (ADEs). Children younger than 5 years of age are most likely to visit the ED for ADEs, according to the CDC.

A study of vaccination exemptions in kids found that some doctors are charging anti-vaccine parents for them. 

Continuing to work with FDA to ease the ongoing shortage of injectable methotrexate, APP Pharmaceuticals this week released another 10,000 vials of preservative-free methotrexate (Methotrexate Injection), a drug used in the treatment of pediatric oncology and hematology

FDA has approved lucinactant (Surfaxin, Discovery Labs) for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS. Surfaxin is the first synthetic, peptide-containing surfactant approved for use in neonatal medicine.